MTOR and age-related macular degeneration: The miR-184 miRNA was shown to promote RPE cells proliferation by the suppression of the AKT2/mTOR pathway, indicating the usefulness of mTOR as a therapeutic target in AMD also with the use of epigenetic regulators [61].